Back to Research Hub
Dr. Reddy's Laboratories Limited
RDY
$13.37+0.14 (+1.06%)
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments.
StreetsValue research for Dr. Reddy's Laboratories Limited (RDY)
Members get the full report for Dr. Reddy's Laboratories Limited: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.